Hepatitis B Vaccine (Recombinant) Market Size, Share, Growth, and Industry Analysis, By Type (10mcg/0.5ml,10mcg/ml), By Application (Newborn,Adult), Regional Insights and Forecast to 2035

Detailed TOC of Global Hepatitis B Vaccine (Recombinant) Market Insights, Forecast to 2029

1 Study Coverage
1.1 Hepatitis B Vaccine (Recombinant) Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 10mcg/0.5ml
1.2.3 10mcg/ml
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Newborn
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts 2018-2029
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Region
2.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2023)
2.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2024-2029)
2.2.4 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2018-2029)
2.3 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts 2018-2029
2.4 Global Hepatitis B Vaccine (Recombinant) Sales by Region
2.4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2023)
2.4.3 Global Hepatitis B Vaccine (Recombinant) Sales by Region (2024-2029)
2.4.4 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers
3.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2018-2023)
3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccine (Recombinant) in 2022
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2018-2023)
3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccine (Recombinant) Revenue in 2022
3.3 Global Key Players of Hepatitis B Vaccine (Recombinant), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Hepatitis B Vaccine (Recombinant) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hepatitis B Vaccine (Recombinant), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hepatitis B Vaccine (Recombinant), Product Offered and Application
3.8 Global Key Manufacturers of Hepatitis B Vaccine (Recombinant), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Type
4.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Type (2018-2023)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Type (2024-2029)
4.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Type
4.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Type (2018-2023)
4.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis B Vaccine (Recombinant) Price by Type
4.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Type (2018-2023)
4.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Hepatitis B Vaccine (Recombinant) Sales by Application
5.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Application (2018-2023)
5.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Application (2024-2029)
5.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Application
5.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Application (2018-2023)
5.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application
5.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Application (2018-2023)
5.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Hepatitis B Vaccine (Recombinant) Market Size by Type
6.1.1 US & Canada Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2029)
6.1.2 US & Canada Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2029)
6.2 US & Canada Hepatitis B Vaccine (Recombinant) Market Size by Application
6.2.1 US & Canada Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2029)
6.2.2 US & Canada Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2029)
6.3 US & Canada Hepatitis B Vaccine (Recombinant) Market Size by Country
6.3.1 US & Canada Hepatitis B Vaccine (Recombinant) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2029)
6.3.3 US & Canada Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hepatitis B Vaccine (Recombinant) Market Size by Type
7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2029)
7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2029)
7.2 Europe Hepatitis B Vaccine (Recombinant) Market Size by Application
7.2.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2029)
7.2.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2029)
7.3 Europe Hepatitis B Vaccine (Recombinant) Market Size by Country
7.3.1 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2029)
7.3.3 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hepatitis B Vaccine (Recombinant) Market Size
8.1.1 China Hepatitis B Vaccine (Recombinant) Sales (2018-2029)
8.1.2 China Hepatitis B Vaccine (Recombinant) Revenue (2018-2029)
8.2 China Hepatitis B Vaccine (Recombinant) Market Size by Application
8.2.1 China Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2029)
8.2.2 China Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hepatitis B Vaccine (Recombinant) Market Size by Type
9.1.1 Asia Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2029)
9.1.2 Asia Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2029)
9.2 Asia Hepatitis B Vaccine (Recombinant) Market Size by Application
9.2.1 Asia Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2029)
9.2.2 Asia Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2029)
9.3 Asia Hepatitis B Vaccine (Recombinant) Sales by Region
9.3.1 Asia Hepatitis B Vaccine (Recombinant) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2029)
9.3.3 Asia Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Market Size by Type
10.1.1 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Market Size by Application
10.2.1 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Sales by Country
10.3.1 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 GSK Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Merck Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Dynavax Technologies
11.4.1 Dynavax Technologies Company Information
11.4.2 Dynavax Technologies Overview
11.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dynavax Technologies Recent Developments
11.5 LG Life Sciences
11.5.1 LG Life Sciences Company Information
11.5.2 LG Life Sciences Overview
11.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LG Life Sciences Recent Developments
11.6 KM Biologics
11.6.1 KM Biologics Company Information
11.6.2 KM Biologics Overview
11.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 KM Biologics Recent Developments
11.7 Shenzhen Kangtai Biological Products
11.7.1 Shenzhen Kangtai Biological Products Company Information
11.7.2 Shenzhen Kangtai Biological Products Overview
11.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shenzhen Kangtai Biological Products Recent Developments
11.8 Serum Institute
11.8.1 Serum Institute Company Information
11.8.2 Serum Institute Overview
11.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
12.2 Hepatitis B Vaccine (Recombinant) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccine (Recombinant) Production Mode & Process
12.4 Hepatitis B Vaccine (Recombinant) Sales and Marketing
12.4.1 Hepatitis B Vaccine (Recombinant) Sales Channels
12.4.2 Hepatitis B Vaccine (Recombinant) Distributors
12.5 Hepatitis B Vaccine (Recombinant) Customers
13 Market Dynamics
13.1 Hepatitis B Vaccine (Recombinant) Industry Trends
13.2 Hepatitis B Vaccine (Recombinant) Market Drivers
13.3 Hepatitis B Vaccine (Recombinant) Market Challenges
13.4 Hepatitis B Vaccine (Recombinant) Market Restraints
14 Key Findings in The Global Hepatitis B Vaccine (Recombinant) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer